Alimera Sciences was founded in 2003 and is headquartered in Alpharetta, US

CSO

Sr. Vice President, Regulatory & Medical Affairs

SVP & European Managing Director

President & CFO

SVP of Sales & Marketing

Alimera Sciences has offices in Alpharetta, Berlin, Lisbon and Hampshire

Alpharetta, US (HQ)

6120 Windward Pkwy

Hampshire, GB

Wellesley Rd

Berlin, DE

21 Cicerostraße

Alimera Sciences's revenue was reported to be $6.6 m in Q1, 2017

USD

## Revenue (Q1, 2017) | 6.6 m |

## Net income (Q1, 2017) | (6.7 m) |

## EBIT (Q1, 2017) | (5.5 m) |

## Market capitalization (17-Aug-2017) | 92.3 m |

## Cash (31-Mar-2017) | 26.7 m |

Alimera Sciences's current market capitalization is $92.3 m.

USD | FY, 2013^{} | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|---|

## Revenue | 1.9 m | 8.4 m | 22.4 m | 34.3 m |

## Revenue growth, % | 350% | 166% | 53% | |

## Cost of goods sold | 1.9 m | |||

## Gross profit | 9 k | 7 m | 20.7 m | |

## Gross profit Margin, % | 0% | 83% | 92% | |

## Sales and marketing expense | 29.4 m | |||

## General and administrative expense | 15.3 m | |||

## Operating expense total | 34.4 m | 39.9 m | 59.7 m | 44.7 m |

## EBIT | (46.2 m) | (32.9 m) | (39 m) | (27.8 m) |

## EBIT margin, % | (2469%) | (391%) | (174%) | (81%) |

## Net Income | (46.2 m) | (35.9 m) | (30.6 m) | (33.2 m) |

USD | Q2, 2014^{} | Q3, 2014^{} | Q1, 2015^{} | Q2, 2015^{} | Q3, 2015^{} | Q1, 2016^{} | Q2, 2016^{} | Q3, 2016^{} | Q1, 2017^{} |
---|---|---|---|---|---|---|---|---|---|

## Revenue | 2.2 m | 2.4 m | 3.9 m | 5.8 m | 6.9 m | 5.8 m | 9.6 m | 8.3 m | 6.6 m |

## Cost of goods sold | (376 k) | ||||||||

## Gross profit | 2.6 m | ||||||||

## Gross profit Margin, % | 117% | ||||||||

## Sales and marketing expense | 3.1 m | 3.7 m | 7.1 m | 6.9 m | 6.9 m | 7.1 m | 7.5 m | 7.5 m | 5.5 m |

## R&D expense | 1.8 m | 3.9 m | 3.3 m | ||||||

## General and administrative expense | 2.8 m | 3 m | 3.6 m | 3.8 m | 3 m | 3.4 m | 4 m | 3.6 m | 3.3 m |

## Operating expense total | 7.8 m | 10.6 m | 14.1 m | 10.7 m | 10 m | 10.5 m | 11.5 m | 11.1 m | 8.8 m |

## EBIT | (11 m) | (9.8 m) | (8.4 m) | (8.8 m) | (6.4 m) | (7.2 m) | (5.5 m) | ||

## EBIT margin, % | (279%) | (170%) | (122%) | (152%) | (67%) | (87%) | (83%) | ||

## Net Income | (19.6 m) | (26.7 m) | (9.8 m) | (18.4 m) | (19.9 m) | (11.1 m) | (18 m) | (27.2 m) | (6.7 m) |

USD | FY, 2013^{} | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|---|

## Cash | 12.6 m | 76.7 m | 31.1 m | 31 m |

## Accounts Receivable | 500 k | 850 k | 9.8 m | 13.8 m |

## Inventories | 3.5 m | 3.2 m | 2.7 m | 446 k |

## Current Assets | 18.6 m | 83.3 m | 45.2 m | 47.4 m |

## Total Assets | 19.6 m | 109.4 m | 70.5 m | 70.2 m |

## Accounts Payable | 1.7 m | 5 m | 4 m | 5 m |

## Current Liabilities | 4.9 m | 10.5 m | 39.9 m | 9.1 m |

## Additional Paid-in Capital | 240.1 m | 292.9 m | 299.4 m | 330.8 m |

## Retained Earnings | (277.3 m) | (313.3 m) | (343.9 m) | (377.1 m) |

## Total Equity | 26.3 m | 25.6 m | ||

## Financial Leverage | 2.7 x | 2.7 x |

USD | Q2, 2014^{} | Q3, 2014^{} | Q1, 2015^{} | Q2, 2015^{} | Q3, 2015^{} | Q1, 2016^{} | Q2, 2016^{} | Q3, 2016^{} | Q1, 2017^{} |
---|---|---|---|---|---|---|---|---|---|

## Cash | 42 m | 61.4 m | 61.3 m | 48.1 m | 39.3 m | 23.9 m | 16.6 m | 33.9 m | 26.7 m |

## Accounts Receivable | 1 m | 1.1 m | 3.4 m | 7.7 m | 9.4 m | 9.1 m | 13.3 m | 13.4 m | 10.8 m |

## Inventories | 1.4 m | 1.7 m | 2.1 m | 1.6 m | 1.7 m | 1.4 m | 1.2 m | 913 k | 802 k |

## Current Assets | 47.5 m | 67.3 m | 70.3 m | 61.1 m | 53.4 m | 37.2 m | 34.7 m | 51.6 m | 40.5 m |

## PP&E | 1 m | 2.5 m | 2.7 m | 2.6 m | 2.5 m | 2.3 m | 2.1 m | 1.6 m | |

## Total Assets | 48.7 m | 93.3 m | 96.8 m | 87.3 m | 79 m | 62 m | 58.8 m | 75 m | 62.6 m |

## Accounts Payable | 1.9 m | 2.9 m | 4.7 m | 3.3 m | 3.1 m | 3.9 m | 5.7 m | 3.4 m | 4 m |

## Current Liabilities | 4.2 m | 32 m | 12 m | 15 m | 6.7 m | 42.4 m | 45.2 m | 7.9 m | 6.8 m |

## Additional Paid-in Capital | 282.4 m | 291.7 m | 294.1 m | 295.3 m | 296.9 m | 300.7 m | 302.5 m | 329.5 m | 331.9 m |

## Retained Earnings | (297 m) | (304 m) | (323 m) | (331.6 m) | (333.2 m) | (355 m) | (361.9 m) | (371.1 m) | (383.8 m) |

## Total Equity | 33.3 m | 33.4 m | 16.9 m | 11.8 m | 30 m | 20.1 m | |||

## Financial Leverage | 2.6 x | 2.4 x | 3.7 x | 5 x | 2.5 x | 3.1 x |

USD | FY, 2013^{} | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|---|

## Net Income | (46.2 m) | (35.9 m) | (30.6 m) | (33.2 m) |

## Depreciation and Amortization | 138 k | 659 k | 2.6 m | 2.8 m |

## Accounts Receivable | (483 k) | (444 k) | (8.9 m) | (4.1 m) |

## Inventories | (1.4 m) | 206 k | 405 k | 1 m |

## Accounts Payable | (259 k) | 3 m | (487 k) | 1.1 m |

## Cash From Operating Activities | (37.8 m) | (24.3 m) | (45.4 m) | (25.1 m) |

## Purchases of PP&E | (973 k) | (842 k) | (451 k) | (186 k) |

## Cash From Investing Activities | (973 k) | (25.8 m) | (451 k) | (186 k) |

## Cash From Financing Activities | 1.7 m | 114.7 m | 625 k | 25.4 m |

## Interest Paid | 607 k | 1.2 m | 4.2 m | 4 m |

## Income Taxes Paid | 263 k | 193 k |

USD | Q2, 2014^{} | Q3, 2014^{} | Q1, 2015^{} | Q2, 2015^{} | Q3, 2015^{} | Q1, 2016^{} | Q2, 2016^{} | Q3, 2016^{} | Q1, 2017^{} |
---|---|---|---|---|---|---|---|---|---|

## Net Income | (19.6 m) | (26.7 m) | (9.8 m) | (18.4 m) | (19.9 m) | (11.1 m) | (18 m) | (27.2 m) | (6.7 m) |

## Depreciation and Amortization | 69 k | 151 k | 558 k | 1.2 m | 1.9 m | 689 k | 1.4 m | 2.1 m | 666 k |

## Accounts Receivable | (526 k) | (679 k) | (2.7 m) | (6.8 m) | (8.5 m) | 761 k | (3.5 m) | (3.6 m) | 3.1 m |

## Inventories | 400 k | (9 k) | (455 k) | (16 k) | (88 k) | 164 k | 301 k | 612 k | (361 k) |

## Accounts Payable | 122 k | 1.3 m | 272 k | (1.2 m) | (1.4 m) | (1.5 m) | 264 k | (2.1 m) | (1.1 m) |

## Cash From Operating Activities | (10.2 m) | (15.2 m) | (14.7 m) | (27.7 m) | (36.5 m) | (6.7 m) | (14.2 m) | (22.7 m) | (4.2 m) |

## Purchases of PP&E | (210 k) | (163 k) | (160 k) | (337 k) | (370 k) | (75 k) | (116 k) | (122 k) | (57 k) |

## Cash From Investing Activities | (210 k) | (163 k) | (160 k) | (337 k) | (370 k) | (75 k) | (116 k) | (122 k) | (57 k) |

## Cash From Financing Activities | 39.7 m | 64.7 m | (205 k) | (297 k) | (214 k) | (466 k) | (158 k) | 25.6 m | (38 k) |

## Interest Paid | 224 k | 502 k | 954 k | 1.9 m | 2.9 m | 996 k | 2 m | 3 m | 985 k |

## Income Taxes Paid | 9 k | 13 k | 263 k | 299 k | 11 k |

USD | Y, 2017 |
---|---|

## Revenue/Employee | 52.9 k |

## Financial Leverage | 3.1 x |